β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial – The Lancet (link to abstract – $ for full-text)
Commentary: Beta-blockers linked to better outcomes in some patients with cirrhosis – ACP Gastroenterology (free)
Join our WhatsApp group
Free Updates in All Specialties!
TOP 10 Medical News Stories